SCHEMBL14259451

SCHEMBL14259451

Nc1ccc(-n2ccnc2)cc1O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.58
MAPT P10636 1/20 0.58
ENPP2 Q13822 1/20 0.58
MKNK1 Q9BUB5 1/20 0.58
MKNK2 Q9HBH9 1/20 0.58
CYP19A1 P11511 2/20 0.51
CYP11B1 P15538 2/20 0.51
CYP11B2 P19099 2/20 0.51
HDAC1 Q13547 1/20 0.49
IDO1 P14902 3/20 0.49
NOTUM Q6P988 1/20 0.49
CYP3A4 P08684 2/20 0.47
NCOA3 Q9Y6Q9 1/20 0.46
BAZ2B Q9UIF8 1/20 0.46
MEN1 O00255 1/20 0.46
ALOX15 P16050 1/20 0.46
TSHR P16473 1/20 0.46
KMT2A Q03164 1/20 0.46
PDE2A O00408 1/20 0.46
PDE3B Q13370 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20854609 0.84 ENPP2 (0.63) LMNAMAPTENPP2MKNK1MKNK2
SCHEMBL3490259 0.84 LMNA (0.63) LMNAMAPTENPP2MKNK1MKNK2
SCHEMBL1449607 0.79 LMNA (0.58) LMNAMAPTENPP2MKNK1MKNK2
SCHEMBL6259515 0.79 LMNA (0.58) LMNAMAPTENPP2MKNK1MKNK2
SCHEMBL29495237 0.79 LMNA (0.58) LMNAMAPTENPP2MKNK1MKNK2
SCHEMBL993223 0.79 LMNA (0.58) LMNAMAPTENPP2MKNK1MKNK2
SCHEMBL22393891 0.79 ENPP2 (0.58) LMNAMAPTENPP2MKNK1MKNK2
SCHEMBL12316383 0.78 MKNK1 (0.51) LMNAMAPTENPP2MKNK1MKNK2
SCHEMBL8425351 0.78 MAPT (0.51) LMNAMAPTENPP2MKNK1MKNK2
SCHEMBL26614180 0.78 ADH5 (0.54) LMNAMAPTENPP2MKNK1MKNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022060943-A1 COMPOSITIONS FOR MODULATING SPLICING SKYHAWK THERAPEUTICS, INC. (US) 2022-03-24 WO disclosed
WO-2008025509-A1 BENZOFURAN AND BENZOTHIOPHENE DERIVATIVES USEFUL IN THE TREATMENT OF CANCERS OF THE CENTRAL NERVOUS SYSTEM BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-03-06 WO disclosed